 |
Quimatryx
Last updated: January 26, 2024
Laureano Simon - CEO
Country: Spain | Add Funding
Website: https://quimatryx.com
Quimatryx develops QTX125, a patented HDAC6 selective inhibitor for the treatment of pancreatic cancer.
Website: https://quimatryx.com
Quimatryx develops QTX125, a patented HDAC6 selective inhibitor for the treatment of pancreatic cancer.